In accordance with the in vivo study, both MK-0646 and OSI-906 treatment showed significant increases in apoptosis demonstrating that IGF-1R inhibition elicits pro-apoptotic effects on CRC cells. The gene discussed is IGF1R; the disease is colorectal carcinoma.